News & Updates

Smoking cessation programmes led and administered by community pharmacists appear to be effective, leading to high quitting and abstinence rates, a recent study has found. In contrast, the PharmQuit intervention, a mobile cessation assistance app, does not seem to be significantly better than standard quitting services.

While the mRNA vaccines currently available on the market have gained regulatory nods* for use in children aged 5 or 6 years old**, Moderna’s mRNA-1273 vaccine is setting a “new low” by showing that two 25 μg doses of the vaccine induce a robust immune response in infants/children as young as 6 months to <6 years of age, according to the latest data from the KidCOVE study.

Among patients with interstitial lung disease, cough-specific quality of life (QOL) is independently associated with adverse outcomes, specifically respiratory hospitalization, death, and lung transplantation, as reported in a study.

Treatment with benralizumab significantly reduces exacerbation rates in patients with asthma in a real-world setting, according to the ZEPHYR 2 study presented at AAAAI 2022.

Not only does tezepelumab reduce asthma symptomatic days, it prevents asthma exacerbations across all seasons in adolescents and adults with severe, uncontrolled asthma, according to the prespecified exploratory analyses of the NAVIGATOR trial presented at AAAAI 2022.

Meteorological and environmental factors may be used as early warning signals for wheezing diseases and respiratory virus prevalence in children, a recent China study has found.

Older men with high levels of serum folate seem to be more likely to have better pulmonary function, reports a recent Korea study.